Skip to main content

Advertisement

SpringerLink
Log in

Renin–angiotensin system and progression of chronic liver diseases

  • Editorial
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. A Helmy R Jalan DE Newby PC Hayes DJ Webb (2000) ArticleTitleRole of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis Gastroenterology 118 565–72 Occurrence Handle10702208 Occurrence Handle10.1016/S0016-5085(00)70263-0 Occurrence Handle1:CAS:528:DC%2BD3cXit1Smsbw%3D

    Article  PubMed  CAS  Google Scholar 

  2. JC Garcia-Pagan J Bosch J Rodes (1995) ArticleTitleThe role of vasoactive mediators in portal hypertension Semin Gastrointest Dis 6 140–7 Occurrence Handle7551971 Occurrence Handle1:STN:280:BymD38vgvV0%3D

    PubMed  CAS  Google Scholar 

  3. R Bataller P Gines JM Nicolas MN Gorbig E Garcia-Ramallo X Gasull et al. (2000) ArticleTitleAngiotensin II induces contraction and proliferation of human hepatic stellate cells Gastroenterology 118 1149–56 Occurrence Handle10833490 Occurrence Handle10.1016/S0016-5085(00)70368-4 Occurrence Handle1:CAS:528:DC%2BD3cXktlaiu7w%3D

    Article  PubMed  CAS  Google Scholar 

  4. R Bataller P Sancho-Bru P Gines JM Lora A Al-Garawi M Sole et al. (2003) ArticleTitleActivated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II Gastroenterology 125 117–25 Occurrence Handle12851877 Occurrence Handle10.1016/S0016-5085(03)00695-4 Occurrence Handle1:CAS:528:DC%2BD3sXmtVWqur4%3D

    Article  PubMed  CAS  Google Scholar 

  5. R Bataller P Sancho-Bru Gines DA Brenner (2005) ArticleTitleLiver fibrogenesis: a new role for the renin-angiotensin system Antioxid Redox Signal 7 1346–55 Occurrence Handle16115040 Occurrence Handle10.1089/ars.2005.7.1346 Occurrence Handle1:CAS:528:DC%2BD2MXos1ertL8%3D

    Article  PubMed  CAS  Google Scholar 

  6. H Yoshiji S Kuriyama J Yoshii Y Ikenaka R Noguchi K Yanase et al. (2003) ArticleTitleAngiotensin-II induces the tissue inhibitor of metalloproteinases-1 through the protein kinase-C signaling pathway in rat liver fibrosis development Hepatol Res 27 51–6 Occurrence Handle12957207 Occurrence Handle10.1016/S1386-6346(03)00160-8 Occurrence Handle1:CAS:528:DC%2BD3sXmvFSis7w%3D

    Article  PubMed  CAS  Google Scholar 

  7. Y Ikura M Ohsawa N Shirai Y Sugama H Fukushima T Suekane et al. (2005) ArticleTitleExpression of angiotensin II type 1 receptor in human cirrhotic livers: its relation to fibrosis and portal hypertension Hepatol Res 32 107–16 Occurrence Handle15905119 Occurrence Handle10.1016/j.hepres.2005.01.017 Occurrence Handle1:CAS:528:DC%2BD2MXlvFehsL4%3D

    Article  PubMed  CAS  Google Scholar 

  8. JB Dixon PS Bhathal JR Jonsson AF Dixon EE Powell PE O'Brien (2003) ArticleTitlePro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese J Hepatol 39 967–71 Occurrence Handle14642613 Occurrence Handle10.1016/S0168-8278(03)00459-8 Occurrence Handle1:CAS:528:DC%2BD3sXpt1egtLk%3D

    Article  PubMed  CAS  Google Scholar 

  9. EE Powell CJ Edwards-Smith JL Hay AD Clouston DH Crawford C Shorthouse et al. (2000) ArticleTitleHost genetic factors influence disease progression in chronic hepatitis C Hepatology 31 828–33 Occurrence Handle10733535 Occurrence Handle10.1053/he.2000.6253 Occurrence Handle1:CAS:528:DC%2BD3cXis1Cksr0%3D

    Article  PubMed  CAS  Google Scholar 

  10. M Ueki M Koda S Yamamoto Y Matsunaga Y Murawaki (2006) ArticleTitlePreventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats J Gastroenterol 41 996–1004

    Google Scholar 

  11. JR Jonsson AD Clouston Y Ando LI Kelemen MJ Horn MD Adamson et al. (2001) ArticleTitleAngiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis Gastroenterology 121 148–55 Occurrence Handle11438504 Occurrence Handle10.1053/gast.2001.25480 Occurrence Handle1:CAS:528:DC%2BD3MXlt1yktL4%3D

    Article  PubMed  CAS  Google Scholar 

  12. T Ohishi H Saito K Tsusaka K Toda H Inagaki Y Hamada et al. (2001) ArticleTitleAnti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in rats Hepatol Res 21 147–58 Occurrence Handle11551835 Occurrence Handle10.1016/S1386-6346(01)00102-4 Occurrence Handle1:CAS:528:DC%2BD38Xht1yntrY%3D

    Article  PubMed  CAS  Google Scholar 

  13. H Yoshiji S Kuriyama J Yoshii Y Ikenaka R Noguchi T Nakatani et al. (2001) ArticleTitleAngiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats Hepatology 34 745–50 Occurrence Handle11584371 Occurrence Handle1:CAS:528:DC%2BD3MXns1Kisrs%3D

    PubMed  CAS  Google Scholar 

  14. H Yoshiji J Yoshii Y Ikenaka R Noguchi H Tsujinoue T Nakatani et al. (2002) ArticleTitleInhibition of renin–angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats J Hepatol 37 22–30 Occurrence Handle12076858 Occurrence Handle10.1016/S0168-8278(02)00104-6 Occurrence Handle1:CAS:528:DC%2BD38XksFymurs%3D

    Article  PubMed  CAS  Google Scholar 

  15. K Kanno S Tazuma K Chayama (2003) ArticleTitleAT1A-deficient mice show less severe progression of liver fibrosis induced by CCl(4) Biochem Biophys Res Commun 308 177–83 Occurrence Handle12890498 Occurrence Handle10.1016/S0006-291X(03)01357-3 Occurrence Handle1:CAS:528:DC%2BD3sXlvVCkurw%3D

    Article  PubMed  CAS  Google Scholar 

  16. L Yang R Bataller J Dulyx TM Coffman P Gines RA Rippe et al. (2005) ArticleTitleAttenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice J Hepatol 43 317–23 Occurrence Handle15964094 Occurrence Handle10.1016/j.jhep.2005.02.034 Occurrence Handle1:CAS:528:DC%2BD2MXlvFalsL0%3D

    Article  PubMed  CAS  Google Scholar 

  17. Y Terui T Saito H Watanabe H Togashi S Kawata Y Kamada et al. (2002) ArticleTitleEffect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C Hepatology 36 1022 Occurrence Handle12297856 Occurrence Handle10.1053/jhep.2002.32679

    Article  PubMed  Google Scholar 

  18. S Yokohama M Yoneda M Haneda S Okamoto M Okada K Aso et al. (2004) ArticleTitleTherapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis Hepatology 40 1222–5 Occurrence Handle15382153 Occurrence Handle10.1002/hep.20420 Occurrence Handle1:CAS:528:DC%2BD2cXhtVCgt7jK

    Article  PubMed  CAS  Google Scholar 

  19. A Rimola MC Londono G Guevara M Bruguera M Navasa X Forns et al. (2004) ArticleTitleBeneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation Transplantation 78 686–91 Occurrence Handle15371669 Occurrence Handle10.1097/01.TP.0000128913.09774.CE Occurrence Handle1:CAS:528:DC%2BD2cXnsFGqsrY%3D

    Article  PubMed  CAS  Google Scholar 

  20. H Yoshiji S Kuriyama R Noguchi J Yoshii Y Ikenaka K Yanase et al. (2005) ArticleTitleCombination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development Liver Int 25 153–61 Occurrence Handle15698413 Occurrence Handle10.1111/j.1478-3231.2005.01038.x Occurrence Handle1:CAS:528:DC%2BD2MXisFCqtLo%3D

    Article  PubMed  CAS  Google Scholar 

  21. H Yoshiji R Noguchi S Kuriyama Y Ikenaka J Yoshii K Yanase et al. (2005) ArticleTitleImatinib mesylate (STI-571) attenuates liver fibrosis development in rats Am J Physiol Gastrointest Liver Physiol 288 G907–13 Occurrence Handle15618280 Occurrence Handle10.1152/ajpgi.00420.2004 Occurrence Handle1:CAS:528:DC%2BD2MXktlSnsL8%3D

    Article  PubMed  CAS  Google Scholar 

  22. P Carmeliet (2005) ArticleTitleAngiogenesis in life, disease and medicine Nature 438 932–6 Occurrence Handle16355210 Occurrence Handle10.1038/nature04478 Occurrence Handle1:CAS:528:DC%2BD2MXhtlSksrjF

    Article  PubMed  CAS  Google Scholar 

  23. H Yoshiji S Kuriyama H Fukui (2002) ArticleTitleAngiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor Tumour Biol 23 348–56 Occurrence Handle12677092 Occurrence Handle10.1159/000069792 Occurrence Handle1:CAS:528:DC%2BD3sXis1Cju74%3D

    Article  PubMed  CAS  Google Scholar 

  24. Yoshiji H, Kuriyama S, Noguchi R, Ikenaka Y, Kitade M, Kaji K, et al. Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development. Hepatol Res 2006 in press

  25. H Yoshiji S Kuriyama J Yoshii Y Ikenaka R Noguchi DJ Hicklin et al. (2003) ArticleTitleVascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis Gut 52 1347–54 Occurrence Handle12912869 Occurrence Handle10.1136/gut.52.9.1347 Occurrence Handle1:CAS:528:DC%2BD3sXnsFCgtLs%3D

    Article  PubMed  CAS  Google Scholar 

  26. K Suzuki N Hayashi Y Miyamoto M Yamamoto K Ohkawa Y Ito et al. (1996) ArticleTitleExpression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma Cancer Res 56 3004–9 Occurrence Handle8674055 Occurrence Handle1:CAS:528:DyaK28XjvFCktrY%3D

    PubMed  CAS  Google Scholar 

  27. R Yamaguchi H Yano A Iemura S Ogasawara M Haramaki M Kojiro (1998) ArticleTitleExpression of vascular endothelial growth factor in human hepatocellular carcinoma Hepatology 28 68–77 Occurrence Handle9657098 Occurrence Handle10.1002/hep.510280111 Occurrence Handle1:CAS:528:DyaK1cXks1aqsLo%3D

    Article  PubMed  CAS  Google Scholar 

  28. K Hori S Saito H Takahashi H Sato H Maeda Y Sato (2000) ArticleTitleTumor-selective blood flow decrease induced by an angiotensin converting enzyme inhibitor, temocapril hydrochloride Jpn J Cancer Res 91 261–9 Occurrence Handle10761715 Occurrence Handle1:CAS:528:DC%2BD3cXhsVygu7s%3D

    PubMed  CAS  Google Scholar 

  29. H Yoshiji S Kuriyama R Noguchi H Fukui (2004) ArticleTitleAngiotensin-I converting enzyme inhibitors as potential anti-angiogenic agents for cancer therapy Curr Cancer Drug Targets 4 555–67 Occurrence Handle15578913 Occurrence Handle10.2174/1568009043332790 Occurrence Handle1:CAS:528:DC%2BD2cXhtVWitbfI

    Article  PubMed  CAS  Google Scholar 

  30. R Noguchi H Yoshiji S Kuriyama J Yoshii Y Ikenaka K Yanase et al. (2003) ArticleTitleCombination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis Clin Cancer Res 9 6038–45 Occurrence Handle14676130 Occurrence Handle1:CAS:528:DC%2BD3sXpsl2lsLk%3D

    PubMed  CAS  Google Scholar 

  31. H Yoshiji S Kuriyama R Noguchi J Yoshii Y Ikenaka K Yanase et al. (2005) ArticleTitleCombination of vitamin K(2) and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression J Hepatol 42 687–93 Occurrence Handle15826718 Occurrence Handle10.1016/j.jhep.2004.12.025 Occurrence Handle1:CAS:528:DC%2BD2MXjtFyktLw%3D

    Article  PubMed  CAS  Google Scholar 

  32. S Frachon G Gouysse J Dumorti A Couvelard M Nejjari F Mion et al. (2001) ArticleTitleEndothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study J Hepatol 34 850–7 Occurrence Handle11451168 Occurrence Handle10.1016/S0168-8278(01)00049-6 Occurrence Handle1:STN:280:DC%2BD38%2FitFSjsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  33. R Mazzanti L Messerini L Monsacchi G Buzzelli AL Zignego M Foschi et al. (1997) ArticleTitleChronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis Hepatology 25 229–34 Occurrence Handle8985296 Occurrence Handle10.1002/hep.510250142 Occurrence Handle1:STN:280:ByiC3sfislQ%3D

    Article  PubMed  CAS  Google Scholar 

  34. H Yoshiji S Kuriyama J Yoshii Y Ikenaka R Noguchi DJ Hicklin et al. (2004) ArticleTitleHalting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice Hepatology 39 1517–24 Occurrence Handle15185292 Occurrence Handle10.1002/hep.20218 Occurrence Handle1:CAS:528:DC%2BD2cXlsVWrsbs%3D

    Article  PubMed  CAS  Google Scholar 

  35. H Yoshiji R Noguchi S Kuriyama J Yoshii Y Ikenaka K Yanase et al. (2005) ArticleTitleSuppression of renin-angiotensin system attenuates hepatocarcinogenesis via angiogenesis inhibition in rats Anticancer Res 25 3335–40 Occurrence Handle16101147 Occurrence Handle1:CAS:528:DC%2BD2MXps1Kgt7Y%3D

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Third Department of Internal Medicine, Nara Medical University, 840 Shijo, Kashihara, 634-8522, Japan

    Hitoshi Yoshiji M.D., Ph.D. & Hiroshi Fukui M.D., Ph.D.

Authors
  1. Hitoshi Yoshiji M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroshi Fukui M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoshiji, H., Fukui, H. Renin–angiotensin system and progression of chronic liver diseases. J Gastroenterol 41, 1020–1022 (2006). https://doi.org/10.1007/s00535-006-1897-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-006-1897-8

Keywords

Search

Navigation